BioSpace News Archive

Drug Development

Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications

Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications.

October 23, 2023
·
5 min read
Genetown

Iterative Health Presents Award-Winning Research on the Benefits of Gastroenterological Technology at the American College of Gastroenterology Annual Scientific Meeting

Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, announced today the results of new research unveiled at the American College of Gastroenterology (ACG) Annual Scientific Meeting.

October 23, 2023
·
6 min read
Policy

Certa Therapeutics’ FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis

Certa Therapeutics, a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, announces that the U.S. Food and Drug Administration granted Orphan Drug Designation for its investigational therapy FT011 for the treatment of systemic sclerosis.

October 23, 2023
·
5 min read
BioCapital

NImmune Biopharma Announces Positive Results of Omilancor in Ulcerative Colitis and Crohn’s disease at the American College of Gastroenterology 2023 Annual Scientific Meeting

NImmune Biopharma, (“NImmune”), announced that it will present three abstracts, including final Phase 2 data for omilancor in active Ulcerative Colitis patients at the American College of Gastroenterology (“ACG”) 2023 Annual Scientific Meeting (“ACG 2023”).

October 23, 2023
·
10 min read
Business

Calliditas Therapeutics’ nomination committee composition for the AGM 2024

It is hereby announced that Calliditas Therapeutics’s major owners have appointed a nomination committee for the AGM 2024.

October 23, 2023
·
2 min read
Biotech Bay

Genesis MedTech initiates enrolment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation

Genesis MedTech, a leading medical device company, announced initiation of enrolment in its North American Early Feasibility Study using its dedicated TAVR system, J-Valve™ Transfemoral System.

October 23, 2023
·
3 min read
Lone Star Bio

Versant Diagnostics Partners with Dahl-Chase Pathology and Diagnostic Groups

Versant Diagnostics announced its collaboration with Bangor, Maine-based Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic Services.

October 23, 2023
·
2 min read
Drug Development

Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress

Bolt Biotherapeutics (Nasdaq: BOLT) today presented updated data from its Phase 1 dose-escalation trial of BDC-1001 at the European Society for Medical Oncology (ESMO) 2023 Congress, being held in Madrid, Spain and virtually from October 20-24, 2023.

October 23, 2023
·
8 min read
Drug Development

Landmark Phase 3 MARIPOSA Study Shows RYBREVANT® (amivantamab-vmjw) Plus Lazertinib Resulted in 30 Percent Reduction in Risk of Disease Progression or Death Compared to Osimertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase 3 MARIPOSA study showing RYBREVANT®.

October 23, 2023
·
22 min read
Business

Agilent to Announce Fourth-Quarter Fiscal Year 2023 Financial Results Nov. 20

Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2023 after the stock market closes on Monday, Nov. 20.

October 23, 2023
·
1 min read